
What's New
Outcome of the Consultation on the Proposal to Change the Regulatory and Funding Restrictions for Stimulant Treatments for ADHD
Following public consultation with Pharmac, Medsafe has made the decision to change the regulatory restrictions on who can initiate prescribing of stimulant medicines for ADHD.